Figure 2.

Immunotherapies targeting BCMA in clinical development. This figure shows various anti-BCMA agents in current clinical trials. The major enrollment criteria or characteristics of participants are also indicated. Every effort has been made to obtain reliable data from multiple sources including http://clinicaltrials.gov/, company, and other web sites, but accuracy cannot be fully guaranteed to date.